tag:blogger.com,1999:blog-4625300644378340826.post1308915051948107282..comments2022-12-31T10:49:42.366-08:00Comments on Mission Tumor: Cost of Cancer Drug Development, 4 Billion. Cost to Patient, 0.1 Million. Benefit, Priceless! Business Model, UnsustainableAjay K Malik, PhDhttp://www.blogger.com/profile/16832364780076934613noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-4625300644378340826.post-84755763196272172072012-07-08T10:51:25.915-07:002012-07-08T10:51:25.915-07:00also a good read:
Do oncologists have an incenti...also a good read: <br /><br /><a href="http://www.kevinmd.com/blog/2012/07/oncologists-incentive-prescribe-expensive-treatments.html" rel="nofollow">Do oncologists have an incentive to prescribe expensive treatments?</a><br />by PETER UBEL, MD at KevinMD.com<br /><br />A recent economic analysis concluded that patients with metastatic cancer value their treatments significantly more than regulators recognize, with many expensive new therapies looking like veritable bargains to most patients. Yet the study ignored the values really driving oncology spending—the warped incentives oncologists have to promote their own bottom line by prescribing expensive treatments...Ajay K Malik, PhDhttps://www.blogger.com/profile/16832364780076934613noreply@blogger.com